Related Experiment Video
Updated: Aug 10, 2026

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Effects of nifedipine on baroreflex modulation of vascular resistance in man
Abstract:
Studies in animals have demonstrated that, in addition to their vascular effects, calcium channel blockers have important effects on baroreceptor function. We performed a series of experiments to determine if nifedipine, in doses employed clinically, alters baroreflex control of vascular resistance in normal humans. Forearm vasoconstrictor responses of 14 normal subjects to unloading of baroreceptors with lower body negative pressure (LBNP), to a cold pressor test and during intra-arterial infusions of norepinephrine were studied in the control state and following administration of nifedipine. Nifedipine had no effect on baseline mean arterial pressure or central venous pressure. Heart rate and forearm blood flow (FBF) increased significantly following nifedipine: heart rate = 59.7 +/- 2.4 bpm before and 72.6 +/- 4.4 bpm after nifedipine (mean +/- SE, p less than 0.001, n = 14); FBF = 4.6 +/- 0.4 ml X min-1 X 100 ml-1 before and 6.7 +/- 1.0 ml X min1 X 100 ml-1 after nifedipine (p less than 0.02, n = 14). Forearm vascular resistance (FVR) tended to decrease following nifedipine but the difference was not significant: FVR = 21.1 +/- 1.4 units before and 17.8 +/- 2.3 units after nifedipine (p = 0.07, n = 14). Nifedipine attenuated forearm vasoconstrictor responses to cold pressor stimulus: delta FVR during cold pressor test = +10.3 +/- 2.4 units before and +4.7 +/- 1.4 units after nifedipine (p less than 0.02, n = 14). Likewise, nifedipine depressed vasoconstrictor responses to intra-arterial infusion of norepinephrine: delta FVR during norepinephrine = +15.5 +/- 3.4 units before and +10.2 +/- 2.9 units after nifedipine (p less than 0.05, n = 7).(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Nifedipine, a calcium channel blocker, was studied in humans and found to alter baroreflex control of vascular resistance. This medication reduced vasoconstrictor responses to cold stimuli and norepinephrine, impacting blood pressure regulation.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
Background:
- Calcium channel blockers (CCBs) exhibit vascular effects and influence baroreceptor function.
- Clinical doses of nifedipine's impact on human baroreflex control of vascular resistance require investigation.
Purpose of the Study:
- To determine if clinically relevant doses of nifedipine alter baroreflex control of vascular resistance in normal humans.
Main Methods:
- 14 healthy subjects underwent experiments assessing forearm vasoconstrictor responses.
- Responses were measured during lower body negative pressure, cold pressor tests, and norepinephrine infusions.
- Measurements were taken both before and after nifedipine administration.
Main Results:
- Nifedipine increased heart rate and forearm blood flow, tending to decrease forearm vascular resistance.
- Nifedipine significantly attenuated vasoconstrictor responses to cold pressor stimuli.
- Nifedipine also depressed vasoconstrictor responses to intra-arterial norepinephrine infusion.
Conclusions:
- Nifedipine affects baroreflex control of vascular resistance in humans.
- The drug impairs the body's ability to constrict blood vessels in response to certain stimuli.
More Related Videos
09:56Implantation of Combined Telemetric ECG and Blood Pressure Transmitters to Determine Spontaneous Baroreflex Sensitivity in Conscious Mice
Published on: February 14, 2021
08:46Real-time Evaluation of Absolute, Cytosolic, Free Ca2+ and Corresponding Contractility in Isolated, Pressurized Lymph Vessels
Published on: March 22, 2024
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Vasodilators
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...